Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer

被引：0
|
作者：
A. Matrone
A. Prete
A. Nervo
A. Ragni
L. Agate
E. Molinaro
C. Giani
L. Valerio
E. Minaldi
A. Piovesan
R. Elisei
机构：
[1] Pisa University Hospital,Department of Clinical and Experimental Medicine, Unit of Endocrinology
[2] Azienda Ospedaliero Universitaria Città Della Salute E Della Scienza Di Torino,Department of Oncology, Oncological Endocrinology Unit
来源：
Journal of Endocrinological Investigation | 2021年 / 44卷
关键词：
Lenvatinib; Medullary thyroid cancer; Calcitonin; Carcinoembrionic antigen; Tyrosine kinase inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2139 / 2151
页数：12
相关论文
共 50 条
  • [11] Anlotinib for the Treatment of Patients with Locally Advanced or Metastatic Medullary Thyroid Cancer
    Sun, Yongkun
    Du, Feng
    Gao, Ming
    Ji, Qinghai
    Li, Zhendong
    Zhang, Yuan
    Guo, Zhuming
    Wang, Jun
    Chen, Xiangjin
    Wang, Jinwan
    Chi, Yihebali
    Tang, Pingzhang
    THYROID, 2018, 28 (11) : 1455 - 1461
  • [12] Salvage tyrosine kinase inhibitor therapy for differentiated and medullary thyroid cancer.
    Chowdry, R. P.
    Bhimani, C.
    Ramalingam, S. S.
    Khuri, F. R.
    Owonikoko, T. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [13] Lenvatinib rechallenge after failure of lenvatinib and sorafenib in metastatic thyroid cancer
    Yokota, Tomoya
    Hamauchi, Satoshi
    Kawakami, Takeshi
    Fushiki, Kunihiro
    INVESTIGATIONAL NEW DRUGS, 2024, 42 (04) : 361 - 368
  • [14] EFFICACY OF RADIOIODINE THERAPY PLUS LOW DOSE LENVATINIB IN ADVANCED METASTATIC DIFFERENTIATED THYROID CANCER: A RANDOMIZED CONTROLLED TRIAL
    Singareddy, Chandra Teja Reddy
    Satapathy, Swayamjeet
    Ballal, Sanjana
    Tripathi, Madhavi
    Bal, Chandrasekhar
    Sahoo, Ranjit
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [15] Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
    Wells, Samuel A., Jr.
    Gosnell, Jessica E.
    Gagel, Robert F.
    Moley, Jeffrey
    Pfister, David
    Sosa, Julie A.
    Skinner, Michael
    Krebs, Annetta
    Vasselli, James
    Schlumberger, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (05) : 767 - 772
  • [16] Outcome of Patients with Locally Advanced Metastatic Medullary Thyroid Cancer and Induction Therapy with Tyrosine Kinase Inhibitors in Slovenia
    Grasic Kuhar, Cvetka
    Lozar, Taja
    Besic, Nikola
    Music Marolt, Maja
    ADVANCES IN THERAPY, 2021, 38 (12) : 5684 - 5699
  • [17] Outcome of Patients with Locally Advanced Metastatic Medullary Thyroid Cancer and Induction Therapy with Tyrosine Kinase Inhibitors in Slovenia
    Cvetka Grasic Kuhar
    Taja Lozar
    Nikola Besic
    Maja Music Marolt
    Advances in Therapy, 2021, 38 : 5684 - 5699
  • [18] Treatment of advanced medullary thyroid cancer
    Smit J.
    Thyroid Research, 6 (Suppl 1)
  • [19] Management of advanced medullary thyroid cancer
    Hadoux, Julien
    Pacini, Furio
    Tuttle, R. Michael
    Schlumberger, Martin
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (01): : 64 - 71
  • [20] Systemic treatment of advanced, metastatic, medullary thyroid carcinoma
    Matrone, Antonio
    Gambale, Carla
    Prete, Alessandro
    Cappagli, Virginia
    Lorusso, Loredana
    Bottici, Valeria
    Elisei, Rossella
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2021, 7
12345